Valuation : Vivos Therapeutics, Inc.

Market Cap 3.62M 3.11M 2.92M 2.67M 4.98M 343M 5.01M 34.65M 13.41M 175M 13.58M 13.28M 557M P/E 2026 *
-0.13x
P/E 2027 * -0.22x
Enterprise Value 3.62M 3.11M 2.92M 2.67M 4.98M 343M 5.01M 34.65M 13.41M 175M 13.58M 13.28M 557M EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.11x
Free-Float
79.95%
Yield 2026 *
-
Yield 2027 * -
1 day-3.73%
1 week+1.16%
Current month-10.87%
1 month-45.01%
3 months-75.05%
6 months-86.86%
Current year-91.39%
1 week 0.16
Extreme 0.164
0.19
1 month 0.16
Extreme 0.1575
0.46
Current year 0.16
Extreme 0.1575
2.69
1 year 0.16
Extreme 0.1575
3.98
3 years 0.16
Extreme 0.1575
48.79
5 years 0.16
Extreme 0.1575
144.25
10 years 0.16
Extreme 0.1575
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 01/09/2016
Chief Executive Officer 68 01/09/2016
Director TitleAgeSince
Chairman 68 01/06/2020
Director/Board Member 87 01/06/2020
Director/Board Member 59 01/06/2020
Date Insider Type Main position Quantity % Market Cap. Importance
31/7/26 Free

Chief Financial Officer

400,000 2.8788%
30/6/26
Seneca Partners, Inc.
BuyCompany 2,749,330 19.7870%
30/6/26
Seneca Partners, Inc.
OtherCompany 2,749,330 19.7870%
Change 5-day change 1-year change 3-year change Capi.($)
-3.73%+1.16%-95.48%-97.21% 3.62M
+0.39%-0.79%+11.55%+6.74% 12.58B
-0.29%-2.94%+12.01%+25.59% 6.81B
-2.38%-3.60% - - 6.55B
-1.57%-9.44%+21.27%+8.45% 5.7B
-1.35%-4.04%-24.49%+40.77% 4.97B
+0.39%-1.91%-35.88%-21.66% 3.81B
-2.37%-8.92%+28.28%-20.74% 1.96B
+5.33%+3.37%+1.32%+138.52% 1.72B
+0.98%-0.65%+45.63%-16.87% 1.62B
Average -0.46%-1.97%-3.98%+7.07% 4.57B
Weighted average by Cap. -0.45%-2.31%+5.65%+15.25%

Financials

2026 *2027 *
Net sales 21.79M 18.73M 17.62M 16.08M 30.02M 2.07B 30.17M 209M 80.79M 1.06B 81.82M 80.03M 3.36B 34.09M 29.31M 27.57M 25.16M 46.96M 3.23B 47.2M 327M 126M 1.65B 128M 125M 5.26B
Net income -23.53M -20.23M -19.04M -17.37M -32.42M -2.23B -32.59M -226M -87.26M -1.14B -88.37M -86.44M -3.63B -14.7M -12.64M -11.89M -10.85M -20.26M -1.39B -20.36M -141M -54.52M -712M -55.21M -54.01M -2.27B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
268
Date Price Change Volume
09/09/26 USD 0.1757 -2.23% 38,077,704
08/09/26 USD 0.1797 -3.59% 5,096,654
04/09/26 USD 0.1864 +6.76% 4,503,850
03/09/26 USD 0.1746 +1.10% 4,055,948
02/09/26 USD 0.1727 +2.43% 7,570,828
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.1797USD
Average target price
2.117USD
Spread / Average Target
+1,077.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!